Metro Healthcare Berhad (0329.KL) stock: key figures, P/E, revenue and dividend

Health Care · Malaysia

Price
0.22 MYR
Market cap
215.36 m MYR
P/E (2025)
36.74
P/S (2025)
4.27
Dividend yield
1.14 %
Net margin
11.63 %
Return on equity (ROE)
7.80 %
Return on assets (ROA)
6.34 %

Metro Healthcare Berhad financials

Fiscal year20242025
Revenue48.65 m MYR50.42 m MYR
Gross profit19.73 m MYR18.96 m MYR
Operating income7.39 m MYR6.92 m MYR
EBIT7.87 m MYR8.79 m MYR
Net income4.56 m MYR5.86 m MYR
Diluted EPS – continuing operations0.00 MYR0.01 MYR

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Metro Healthcare Berhad

Metro Healthcare Berhad, together with its subsidiaries, provides hospital and related services in Malaysia. It offers inpatient; outpatient; and ambulatory care, including in vitro fertilization (IVF), intrauterine insemination (IUI), blastocyst culture, surgical sperm retrieval, preimplantation genetic screening (PGT), and assisted hatching services. The company also provides fertility services, such as assisted reproductive technology and specialized fertility procedures; and obstetrics services that include pre-pregnancy screening and counselling, family planning counselling, antenatal checkup, and delivery services. In addition, it offers gynecology services, including hysterectomy, oophorectomy, colposcopy, hysteroscopy, laparoscopy, tubal ligation, dilation and curettage, and marsupialization; pediatrics services; diagnostic imaging services; and other healthcare services. Metro Healthcare Berhad was founded in 1989 and is based in Klang, Malaysia.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.